Fairvalue-Calculator Fairvalue-Calculator
EN DE

Azelis Group (AZLGF) Fair Value & Analysis

Basic Materials · US · Market cap $2.8B

Price$11.62
Fair Value$11.17
Upside-3.9%
Quality95/100
Evidence: High Range $8.49 – $16.51

Analysis

Azelis Group (AZLGF) currently trades at $11.62, while our model-based Fair Value estimate is $11.17 — implying the stock looks roughly 3.9% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

Open the full interactive analysis →

Similar stocks

Linde plc (LIN) -57% L'Air Liquide S.A (AIQUY) -59% Air Products and Chemicals, Inc (A1PD34) -70% Intercontinental Exchange, Inc (I1CE34) -15% Wanhua Chemical Group (600309) -31% Asian Paints Limited (ASIANPAINT) -76%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.